Abstract
The purpose of this study was to investigate the effect of ciprofloxacin treatment on quality of life and symptom improvement in patients with simple cystitis. Between January 2010 and December 2010, ciprofloxacin was administered twice daily for 5 days, and changes in the patients’ symptoms, the therapeutic effects, and changes in the Korean version of the Urinary Tract Infection Symptoms Assessment (UTISA) score were evaluated. Patients were classified into two groups according to the self-reported degree of symptom improvement. Significant improvement was noted in symptoms such as frequency, urgency, dysuria, tenesmus, lower abdominal discomfort, back pain, and gross hematuria. The treatment success group comprised 249 patients and the treatment failure group comprised 45 patients. Baseline frequency and urgency, tenesmus, and lower abdominal discomfort were worse in the treatment failure group, although the difference was significant only for frequency (p = 0.029) and urgency (p = 0.028). All UTISA subcategory scores showed improvement in the treatment success group, and the median time to symptom improvement was 2.40 days. In the treatment failure group, some UTISA subcategory scores showed significant improvement, including those for dysuria (1.67 to 0.89), tenesmus (1.76 to 1.08), and gross hematuria (0.80 to 0.21), although significant improvement in frequency, urgency, lower abdominal discomfort, and back pain was not observed. The UTISA questionnaire was useful in reflecting the severity of simple cystitis symptoms. Frequency, urgency, lower abdominal discomfort, and back pain were not adequately improved in the treatment failure group, with frequency and urgency being predisposing factors for treatment failure.
Similar content being viewed by others
References
Foxman B (1990) Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80:331–333
Iravani A (1993) Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 94:89S–96S
Schaeffer AJ (2003) The expanding role of fluoroquinolones. Dis Mon 49:129–147. doi:10.1067/mda.2003.12
Jancel T, Dudas V (2002) Management of uncomplicated urinary tract infections. West J Med 176:51–55
Garrison J, Hooton TM (2001) Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women. Expert Opin Pharmacother 2:1227–1237. doi:10.1517/14656566.2.8.1227
Baerheim A, Digranes A, Jureen R, Malterud K (2003) Generalized symptoms in adult women with acute uncomplicated lower urinary tract infection: an observational study. MedGenMed 5:1
Reid G, Bruce AW (2003) Urogenital infections in women: can probiotics help? Postgrad Med J 79:428–432
Min KS, Kim YH, Kim JM, Shin KL, Hong JY, Kim ME (2009) Development of a Korean version of the urinary tract infection symptoms assessment questionnaire. Korean J Urol 50:361–368
Hooton TM, Stamm WE (1997) Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11:551–581
Nicolle LE (2001) Epidemiology of urinary tract infections. Infect Med 18:153–162
Kunin CM (1994) Urinary tract infections in females. Clin Infect Dis 18:1–10, quiz 11–12
Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49:53–70. doi:10.1067/mda.2003.7
Ellis AK, Verma S (2000) Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract 13:392–397
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Clayson D, Wild D, Doll H, Keating K, Gondek K (2005) Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int 96:350–359. doi:10.1111/j.1464-410X.2005.05630.x
Ernst EJ, Ernst ME, Hoehns JD, Bergus GR (2005) Women’s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes 3:45. doi:10.1186/1477-7525-3-45
Klimberg I, Shockey G, Ellison H, Fuller-Jonap F, Colgan R, Song J, Keating K, Cyrus P (2005) Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin 21:1241–1250. doi:10.1185/030079905x56358
Colgan R, Keating K, Dougouih M (2004) Survey of symptom burden in women with uncomplicated urinary tract infections. Clin Drug Investig 24:55–60
Naber KG, Landen H (2004) Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection. Int J Antimicrob Agents 23(Suppl 1):S35–S40. doi:10.1016/j.ijantimicag.2003.09.010
Butrick CW (2003) Interstitial cystitis and chronic pelvic pain: new insights in neuropathology, diagnosis, and treatment. Clin Obstet Gynecol 46:811–823
Cervero F (1994) Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 74:95–138
Acknowledgments
This study was conducted by project KAUTII & Schbc-UTI-QoL-Kor-2009 and sponsored by Bayer Corporation pharmaceutical company.
Conflict of interest
The authors have provided no information on sources of funding or on conflicts of interestdirectly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Choi, H., Kim, Y.H. & Bae, J.H. Quality of life and changes in symptom relief in patients with acute uncomplicated cystitis treated with antibiotics: a prospective, open-label, multicenter, observational study. Eur J Clin Microbiol Infect Dis 34, 1119–1124 (2015). https://doi.org/10.1007/s10096-015-2329-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-015-2329-6